Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DESCARTES: De-ESCAlation of RadioTherapy in Patients With Pathologic Complete rESponse to Neoadjuvant Systemic Therapy

NCT05416164 is registered in ClinicalTrials.gov with The Netherlands Cancer Institute as lead sponsor.

NCT NCT05416164
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05416164 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DESCARTES: De-ESCAlation of RadioTherapy in Patients With Pathologic Complete rESponse to Neoadjuvant Systemic Therapy
Lead sponsor
The Netherlands Cancer Institute
Phase
Not applicable
Overall status
Recruiting
Start date
October 7, 2022
Completion date
May 31, 2037
Enrollment
595 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer